31384761 33677248 21324537 22153347 26797608 31384813 31384837 36116527 31755386 36221180 23031649 32391496 20716024 - Search Results

Year	Number of Results
2010	1
2011	2
2012	2
2016	1
2019	3
2020	2
2021	1
2022	2
2023	0

1

4-(2-(1H-Benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamides: design, synthesis and biological evaluation.

Tahlan S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B. Tahlan S, et al. BMC Chem. 2019 Feb 2;13(1):12. doi: 10.1186/s13065-019-0533-7. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384761 Free PMC article.

2

Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies.

Sana S, Reddy VG, Srinivasa Reddy T, Tokala R, Kumar R, Bhargava SK, Shankaraiah N. Sana S, et al. Bioorg Chem. 2021 May;110:104765. doi: 10.1016/j.bioorg.2021.104765. Epub 2021 Feb 24. Bioorg Chem. 2021. PMID: 33677248

3

Histamine receptors in the CNS as targets for therapeutic intervention.

Passani MB, Blandina P. Passani MB, et al. Trends Pharmacol Sci. 2011 Apr;32(4):242-9. doi: 10.1016/j.tips.2011.01.003. Epub 2011 Feb 15. Trends Pharmacol Sci. 2011. PMID: 21324537 Review.

4

Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H₁-antihistamines for insomnia.

Ravula SB, Yu J, Tran JA, Arellano M, Tucci FC, Moree WJ, Li BF, Petroski RE, Wen J, Malany S, Hoare SR, Madan A, Crowe PD, Beaton G. Ravula SB, et al. Bioorg Med Chem Lett. 2012 Jan 1;22(1):421-6. doi: 10.1016/j.bmcl.2011.10.115. Epub 2011 Nov 15. Bioorg Med Chem Lett. 2012. PMID: 22153347

5

Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.

Yang Y, Li Y, Pan Y, Wang J, Lin F, Wang C, Zhang S, Yang L. Yang Y, et al. Int J Mol Sci. 2016 Jan 19;17(1):129. doi: 10.3390/ijms17010129. Int J Mol Sci. 2016. PMID: 26797608 Free PMC article.

6

Benzimidazole scaffolds as promising antiproliferative agents: a review.

Tahlan S, Kumar S, Kakkar S, Narasimhan B. Tahlan S, et al. BMC Chem. 2019 May 15;13(1):66. doi: 10.1186/s13065-019-0579-6. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384813 Free PMC article. Review.

7

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents.

Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B. Tahlan S, et al. BMC Chem. 2019 Jul 11;13(1):90. doi: 10.1186/s13065-019-0608-5. eCollection 2019 Dec. BMC Chem. 2019. PMID: 31384837 Free PMC article.

8

Systems pharmacology aiding benzimidazole scaffold as potential lead compounds against leishmaniasis for functional therapeutics.

Kumar A, Nimsarkar P, Singh S. Kumar A, et al. Life Sci. 2022 Nov 1;308:120960. doi: 10.1016/j.lfs.2022.120960. Epub 2022 Sep 15. Life Sci. 2022. PMID: 36116527

9

Benzimidazole: A Milestone in the Field of Medicinal Chemistry.

Vasava MS, Bhoi MN, Rathwa SK, Jethava DJ, Acharya PT, Patel DB, Patel HD. Vasava MS, et al. Mini Rev Med Chem. 2020;20(7):532-565. doi: 10.2174/1389557519666191122125453. Mini Rev Med Chem. 2020. PMID: 31755386 Review.

10

Synthesis and Anti-Cancer Applications of Benzimidazole Derivatives - Recent Studies.

Tyagi YK, Jali G, Singh R. Tyagi YK, et al. Anticancer Agents Med Chem. 2022;22(19):3280-3290. doi: 10.2174/1871520622666220429134818. Anticancer Agents Med Chem. 2022. PMID: 36221180 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results